This compound is a pharmaceutical impurity reference standard, specifically a pyrazinoyl derivative of phenylalanine. It is characterized by the presence of both an amide and a carboxylic acid functional group, along with aromatic and heterocyclic ring systems.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 1093959-75-1
N-[(2R)-2-Hydroxy-2-(3-hydroxyphenyl)ethyl]-N-methyl-glycine
Pharmaceutical intermediate for phenylephrine related compounds
N-Fmoc-N'-trityl-L-histidine
Protected amino acid for peptide synthesis
Tert-butyl (3R)-3-hydroxypyrrolidine-1-carboxylate
Pharmaceutical intermediate for API synthesis
Methyl 5-(chlorosulfonyl)-2-fluorobenzoate
Pharmaceutical intermediate
N-(Pyrazinylcarbonyl)-L-phenylalanine
Pharmaceutical intermediate
B-[(1R)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid
active pharmaceutical ingredient
Bortezomib
active pharmaceutical ingredient
5-methyl-N-[2-(4-sulfamoylphenyl)ethyl]pyrazine-2-carboxamide
pharmaceutical intermediate
3-phenyl-2-(pyrazine-2-carbonylamino)propanoic acid
DWYZPDHMMZGQAP-UHFFFAOYSA-N
C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C2=NC=CN=C2
—